AMZ 0026

Drug Profile

AMZ 0026

Alternative Names: Abavca; AMZ 0026-H; AMZ-0026; AZC 0027; Perthon

Latest Information Update: 18 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Advanced Plant Pharmaceuticals
  • Developer Amazon Biotech
  • Class Antivirals
  • Mechanism of Action Immunomodulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported HIV infections
  • Discontinued Breast cancer; Coronavirus infections; Lyme disease

Most Recent Events

  • 18 Sep 2015 No recent reports on development identified - Phase-I/II for HIV infections in USA and India (PO)
  • 16 Mar 2012 Phase-I/II development is ongoing in USA
  • 27 Feb 2012 Discontinued - Preclinical for Breast cancer in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top